6.000
+1,69%
2026-10-19
Fundamental Analysis
26 / 100CRubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | -31.8% | -7.9% | 1 / 3 | +998.7% | +1.32 pp | -1.69 pp | +7.2% | 3.14 | 7.30 | 1.449 | +998,7% | 9,0 | +196,3% | 7.30 | 5.72 | +27,6% |
| Pts | 0 | 0 | 4 | 12 | 8 | 4 | 0 | -4 | 4 | |||||||
Valuation annotation:Price: 6.000 (close price on 2026-10-19)EPS (TTM): 821,8
Financial charts
1.Revenue & growth
VND bn1.449Q2/26
1.Revenue & growth
VND bn1.449Q2/26
2.Profit & growth
VND bn9,05Q2/26
3.Profit mix (Penman)
VND bn35,3Q2/26
4.Margins & cost structure
%7.1%Q2/26
5.Returns & cash cycle
% · days5.6%Q2/26
6.Earnings quality & cash
VND bn
7.Asset structure
VND bn3.405Q2/26
8.Funding & debt health
VND bn · times3.405Q2/26
9.Revenue backlog
VND bn55,1Q2/26
10.Valuation
times · %13,2×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %139Q2/26
Adjusted EPS growth, latest quarter
-31.8%
Average adjusted EPS growth, 3 quarters
-7.9%
Quarters at 25%+ growth
1/3
Share dilution rate, 1 year
335%
Source: vnstockData through Q2/26